Price $36.95 |
Market Cap
399M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
10.49
|
P/S
179.11
|
Dividend %
-
|
|
P/CF
41.8
|
P/FCF
-
|
Op. Cash Flow
-11.7K
|
FCF
-1.1
|
|
Op. Margin
-695.30%
|
Net Margin
-614.70%
|
ROE
-33.90%
|
ROI
-5.10%
|
|
ROA
-15.20%
|
EPS Growth
-
|
Current Ratio
6.7
|
Debt/Equity
61.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harrow Health Inc (HROW) | $7.95 | - | - | 197.7M | Strong Buy |
| Medicure Inc (MCUJF) | $1.14 | - | - | 13M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.52 | - | - | 12.34B | Strong Buy |
| Osmotica Pharmaceuticals PLC (OSMT) | $3.56 | - | - | 247.8M | Strong Buy |
| IRIDEX Corporation (IRIX) | $6.50 | - | - | 83.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
